Analysts Project This Stock Could Jump to $14 a Share. You Can Still Invest for $3.50.
The AI company making heart disease easier to detect is offering investors $3.50 investment units that include one convertible preferred share and one warrant, providing investors with access to 2 common shares. Based on analyst 1- year projections, that amounts to a near-term 500% return potential.
| Open | 559.30 | Prev Close | 560.00 |
| High | 572.90 | Low | 558.54 |
| Volume | 508,718 | Volume (Avg) | 989 |
| 52 Week High | 1,160.87 | 52 Week Low | 475.77 |
| Market Cap | 60.6B | PE Ratio | 14.41 |
General
| Name | Regeneron Pharmaceuticals, Inc |
| Ticker | REGN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 15,182 |
About Regeneron Pharmaceuticals, Inc
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia (HoFH) or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; Evkeeza for treatment of HoFH; Ordspono for Follicular lymphoma and Diffuse large B-cell lymphoma; and Veopoz for CD55-deficient protein-losing enteropathy. Further, it develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types; and with Sonoma Biotherapeutics, Inc. to discover, develop, and commercialize engineered regulatory T cell therapies. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.
Highlights
| Analyst Target | 727.87 |
| Market Cap | 60,613,400,000 |
| PE Ratio | 14.41 |
| PEG Ratio | 1.08 |
| EBITDA | 4,466,800,128 |
Valuation
| Trailing PE | 14.11 |
| Forward PE | 14.43 |
| Price/Sales (Trailing 12 Mt.) | 4.18 |
| Price/Book (Most Recent Quarter) | 1.98 |
Technicals
| Beta | 0.31 |
| 52 Week High | 1,160.87 |
| 52 Week Low | 475.77 |
| 50 Day Average | 1.32% |
| 200 Day Average | -7.93% |
Dividend
Regeneron Pharmaceuticals, Inc pays out a dividend of $2.98 per share, with a dividend yield of 0.52%.
REGN's last dividend payment was made to shareholders on September 3, 2025.
They pay out 0.00% of their earnings out as a dividend.
Recent Dividends
| Sep 3, 2025 | $0.88 |
| Jun 6, 2025 | $0.88 |
| Mar 20, 2025 | $0.88 |
FBI Alerts Public on 'Phantom Hacker' Scam That Has Drained Billions From Bank Accounts
The FBI has issued a warning about a sophisticated multi-phase scam known as the "Phantom Hacker."
Takeaways from a hunt for 'secret' fresh water under the North Atlantic seabed
ABOARD LIFTBOAT ROBERT, North Atlantic (AP) — It turns out the Continental Shelf has been holding a secret from the ages. Beneath the sea floor off the U.S. northeast lies an enormous reserve of fresh water whose existence was long unknown, then was suspected and now is confirmed.
This Gold Miner Has the Map, the Metal, and the Momentum - Ad
JPMorgan is forecasting that gold will push past $4,000, and this Nevada operation is positioned to benefit. Historical estimates show its property could hold around 1.8 million ounces of measured and indicated gold, backed by infrastructure and billionaire investors. The company's already producing, refining gold onsite and looking to expand. That's not a dream-stage story-that's a head start.
BrilliA Inc Soars Over 87% After Hours Following Cash Dividend Announcement
BrilliA Inc. shares soared 86.73% in after-hours trading Wednesday after announcing a cash dividend.
Macron Warns World Will Know By Monday If Putin 'Played' Trump Again
French President Emmanuel Macron has voiced apprehensions about Vladimir Putin potentially manipulating President Trump.
White House Insider Buck Sexton: "Trump's Next Move Will Shock the World" - Ad
It could single-handedly reshape the global order... dramatically increase U.S. power... and trigger a massive American market boom the likes of which we haven't seen in 75 years.
Nvidia Q2 Preview: 'Saying This Is The Most Important Stock In The World Is An Understatement' (CORRECTED)
Experts break down the key numbers and items to watch in Nvidia's second quarter earnings.
Stock Of The Day: Breakdown In Archer Aviation?
Shares of Archer Aviation have broken a support level. This can be bearish and would suggest they trend lower.
The Next Palantir Moment Could Be Here - Ad
A $21M market cap company is landing multimillion-dollar contracts with banks and governments. With only 9.7M shares in the float, scarcity could spark explosive moves.
Powerball, Mega Millions Missing Jackpots: What Happens To Unclaimed Lottery Tickets
Powerball is one of the most popular lottery games that can offer hundreds of millions of dollars, or in some cases billions, in potential winnings.
Jim Cramer: Sell Chime, Get This Buy Now Pay Later Stock Instead
Chime Financial, on Aug. 22, announced a strategic partnership with Workday to advance financial wellness in the workplace.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
780,000 pressure washers are under recall after some consumers report explosions and impact injuries
NEW YORK (AP) — About 780,000 pressure washers sold at retailers like Home Depot are being recalled across the U.S. and Canada, due to a projectile hazard that has resulted in fractures and other injuries among some consumers.
Super Micro Computer (SMCI) Shares Are Sliding Tuesday: What's Going On?
Super Micro Computer shares are trading lower Tuesday. The stock is caught in a downdraft affecting the broader semiconductor and high-growth technology sectors.
From Ore to Gold Bars-This Nevada Mine Is Already Producing - Ad
Most juniors explore...Few actually produce. This one's already pouring gold thanks to infrastructure that would cost tens of millions to build today. With major land holdings and room to scale, it's one to watch. Discover the little known gold company that's already producing.
Mortgage Fraud Is Now A Trump-Era Flashpoint—Here's Everything You Need To Know
Given the recent high-profile cases, Benzinga decided to take a closer look at what mortgage fraud is and how it can be committed.
Nvidia, CrowdStrike, Snowflake, CoreWeave, Polestar Automotive: Why These 5 Stocks Are On Investors' Radars Today
U.S. stocks closed higher on Wednesday, with the Dow Jones Industrial Average up 0.3% at 45,565.23.
The AI Blind Spot in Banking - Ad
Banks thought AI would solve compliance. Instead, it's made the problem worse. One breakthrough platform is cutting costs in half while securing every flow.
Homes Have Shrunk To The Smallest Average Size In 20 Years: Here's Why It Happened
Newly built homes in the U.S. are shrinking due to higher mortgage rates and affordability concerns. Buyers are adjusting expectations.
Third Richest Woman In The World Eyes New York Giants Stake For Future Growth
One of the richest women in the world could have her eyes on more sports team ownership with a stake in the New York Giants.
How "Trump's New Dollar" Could Impact Your Wealth - Ad
If you have any money in U.S. dollars... learn how to prepare for "Trump's new dollar"... Because this could be the biggest change to our financial system in 54 years. President Trump even called it: "The greatest revolution in financial technology since the birth of the internet itself."
Asian shares are mostly up after US stocks inch to more records as inflation slows and Oracle soars
MANILA, Philippines (AP) — Asian shares were mostly higher Thursday, buoyed by gains of tech-related stocks after Wall Street inched to more records following a surprisingly encouraging report on inflation and a stunning forecast for growth from Oracle because of the boom.
Trump To Attend APEC Summit In South Korea, Eyes Xi Jinping Meeting Amid Trade Tensions: Report
Donald Trump is planning to attend APEC summit in South Korea, possibly meeting with Xi Jinping and Kim Jong Un.
Is This Elon's Worst Nightmare? - Ad
Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.
Bitcoin, Ethereum, Dogecoin Gain; Solana Slides — Analytics Firm Notes Strong ETH Accumulation By 'Millionaire' and 'Small Billionaire' Investors
Market sentiment in the cryptocurrency space shifted back to “Neutral” on Wednesday, although strong accumulation added momentum for some large-cap coins.
How To Earn $500 A Month From General Mills Stock Ahead Of Q1 Earnings
General Mills offers an annual dividend yield of 4.88% ($2.44 a year). Here's how investors can pocket a regular $500 monthly.
Chase, Bank of America, Wells Fargo Preparing for Big Change - Ad
Do you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. They're preparing for what could be the biggest change to our financial system in 54 years. This could have a huge impact on your wealth.
Bill Holdings Shares Soar On Elliott Management Stake: Is An Activist Battle Brewing?
Bill Holdings stock is trading higher with a new activist investor circling the company. Shareholders could find out if two activists are better than one.
OpenAI To Mass-Produce 1st Proprietary AI Chip With Broadcom, Secures $10 Billion Deal: Report
OpenAI is set to begin mass production of its first proprietary artificial intelligence chip next year through a partnership with Broadcom.
Analysts Project This Stock Could Jump to $14 a Share. You Can Still Invest for $3.50. - Ad
The AI company making heart disease easier to detect is offering investors $3.50 investment units that include one convertible preferred share and one warrant, providing investors with access to 2 common shares. Based on analyst 1- year projections, that amounts to a near-term 500% return potential.
Michael Saylor's Bitcoin-Only Prophecy Not Aging Well As Wall Street Embraces $27 Billion In Ethereum ETFs, Buzz Builds Around XRP And Even Dogecoin
Michael Saylor may now seem comfortable with the rise and adoption of the broader crypto ecosystem, but just over a year ago, he was every bit the staunch Bitcoin (CRYPTO: BTC) maximalist.
Graphic video of Kirk shooting was everywhere online, showing how media gatekeeper role has changed
They were careful with the explicit imagery — as usual. But did it make any difference?
This Gold Miner Has the Map, the Metal, and the Momentum - Ad
JPMorgan is forecasting that gold will push past $4,000, and this Nevada operation is positioned to benefit. Historical estimates show its property could hold around 1.8 million ounces of measured and indicated gold, backed by infrastructure and billionaire investors. The company's already producing, refining gold onsite and looking to expand. That's not a dream-stage story-that's a head start.
Trump's plan for a drug advertising crackdown faces many hurdles
WASHINGTON (AP) — Health Secretary Robert F. Kennedy Jr. and other administration officials are vowing a crackdown on deceptive drug ads, but the effort is likely to face multiple headwinds, including pushback from industry and layoffs among regulators tasked with leading the effort.
Trump's Nvidia Export Deal Collides With AI GAIN Act — Chipmaker Warns New Bill Could Cripple Global Competition
Nvidia warned that a new U.S. bill could hurt its global edge by restricting AI chip exports, while growing pressure pushes tech firms like OpenAI to seek alternatives.
White House Insider Buck Sexton: "Trump's Next Move Will Shock the World" - Ad
It could single-handedly reshape the global order... dramatically increase U.S. power... and trigger a massive American market boom the likes of which we haven't seen in 75 years.
What happens to Trump’s tariffs now that a federal appeals court has knocked them down?
WASHINGTON (AP) — President Donald Trump has audaciously claimed virtually unlimited power to bypass Congress and impose sweeping taxes on foreign products.
What's Happening With Regeneron Pharmaceuticals Stock On Monday?
Regeneron's Phase 3 trials for cat and birch allergies show significant symptom relief and strong safety results, paving the way for future development.
The Next Palantir Moment Could Be Here - Ad
A $21M market cap company is landing multimillion-dollar contracts with banks and governments. With only 9.7M shares in the float, scarcity could spark explosive moves.
Elon Musk's Legal Team Fights To Block OpenAI's Access To Meta's Bid Documents
Elon Musk's legal team has filed a motion to prevent OpenAI from obtaining documents related to a previous $97.4 billion bid for its assets, according to a court filings.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.